Amkor Technology (AMKR)
(Real Time Quote from BATS)
$29.86 USD
+1.33 (4.66%)
Updated Aug 8, 2024 12:00 PM ET
5-Strong Sell of 5 5
B Value B Growth F Momentum A VGM
Price, Consensus and EPS Surprise
AMKR 29.86 +1.33(4.66%)
Will AMKR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMKR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMKR
Amkor Technology, Inc. (AMKR) is Attracting Investor Attention: Here is What You Should Know
Wall Street Analysts Think Amkor Technology (AMKR) Is a Good Investment: Is It?
AMKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amkor Technology (AMKR) Beats Q2 Earnings and Revenue Estimates
Watch These 4 Semiconductor Stocks for Q2 Earnings: Beat or Miss?
What's in the Offing for Amkor (AMKR) This Earnings Season?
Other News for AMKR
3 Under-the-Radar Tech Stocks Primed for Explosive Growth
Amkor Technology's Sell-Off Offers Investors A Strong Buying Opportunity
Pure-Play AI Chip Stocks Declined 5%, On Average, In July
Amkor Technology: Weak Near-Term Guidance Has Created A Buying Opportunity Post-Q2
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session